Evert B. Schimmelpennink, Director at Contineum Therapeutics, Inc. Class A, holds ― shares in Contineum Therapeutics, Inc. Class A (Ticker: CTNM), holds 26.66K shares in Pfenex (Ticker: PFNX), holds ― shares in Ibio (Ticker: IBIO). Most recently, Evert B. Schimmelpennink ― shares of Contineum Therapeutics, Inc. Class A on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Evert B. Schimmelpennink?
The percentage of profitable transactions made by Evert B. Schimmelpennink is 50%.
What is the average return per transaction made by Evert B. Schimmelpennink?
The average return per transaction made by Evert B. Schimmelpennink is 17.80%.
What stocks does Evert B. Schimmelpennink hold?
Evert B. Schimmelpennink holds: CTNM, PFNX, IBIO, LENZ stocks.
What was Evert B. Schimmelpennink’s latest transaction?
Evert B. Schimmelpennink latest transaction was an Uninformative Buy of ―.
What was Evert B. Schimmelpennink's most profitable transaction?
Evert B. Schimmelpennink’s most profitable transaction was an Informative Buy of PFNX stock on September 13, 2018. The return on the trade was 88.40%.
What is Evert B. Schimmelpennink's role in Contineum Therapeutics, Inc. Class A?
Evert B. Schimmelpennink's role in Contineum Therapeutics, Inc. Class A is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.